Search results - 4 results
Early high antibody-titre convalescent plasma for hospitalised COVID-19 patients: DAWn-plasma.
the prospective multicentre DAWN-plasma trial, adult patients hospitalised with COVID-19 were randomised to 4 units of open-label convalescent plasma combined with standard of care (intervention group) ...
A randomized, multicentre, open-label phase II proof-of-concept trial investigating the clinical efficacy and safety of the addition of convalescent plasma to the standard of care in patients hospitalized with COVID-19: the DAWn-Plasma trial.
Verbeke, Geert; Vlieghe, Erika; Jean Cyr Yombi; Laurens Liesenborghs; Peter Verhamme; Geert Meyfroidt Source: Trials, Volume 21, Issue 1 (2020) Keywords: Adult Antibodies, Viral Belgium Combined Modality ...
Population vulnerability to COVID-19 in Europe: a burden of disease analysis
70 years and above; and (ii) rate of YLD for COVID-19 vulnerable health conditions across all ages. Bivariate groupings were established for each outcome and combined to establish overall ...
Performance of five rapid serological tests in mild-diseased subjects using finger prick blood for exposure assessment to SARS-CoV-2.
serological testing includes a risk of false-positive results. Therefore, the selected cohort for RST-validation was based on combined immunoassay (presence of specific antibodies) and RT-qPCR (presence of ...